Please wait while the formulary information is being retrieved.
SULFADIAZINE (SULFADIAZINE)
- AIDS with toxoplasmosis
- Bacterial urinary tract infection
- Congenital toxoplasmosis
- Encephalitis due to toxoplasmosis
- Nocardiosis
- Rheumatic fever prevention
- Toxoplasmosis
500 mg tablet
- 2 tablets (1 gram) by oral route once daily
500 mg tablet
- 2 tablets (1 gram) by oral route once daily
Bacterial urinary tract infection
- 2 tablets (1 gram) by oral route 4 times per day
- 2 tablets (1 gram) by oral route 4 times per day for 3 weeks
- 2 tablets (1 gram) by oral route 4 times per day for 4 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day
- 3 tablets (1.5 gram) by oral route 4 times per day for 3 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day for 4 weeks
Congenital toxoplasmosis
- 2 tablets (1 gram) by oral route 4 times per day
- 2 tablets (1 gram) by oral route 4 times per day for 3 weeks
- 2 tablets (1 gram) by oral route 4 times per day for 4 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day
- 3 tablets (1.5 gram) by oral route 4 times per day for 3 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day for 4 weeks
Encephalitis due to toxoplasmosis
- 2 tablets (1 gram) by oral route 4 times per day
- 2 tablets (1 gram) by oral route 4 times per day for 3 weeks
- 2 tablets (1 gram) by oral route 4 times per day for 4 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day
- 3 tablets (1.5 gram) by oral route 4 times per day for 3 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day for 4 weeks
Nocardiosis
- 2 tablets (1 gram) by oral route 4 times per day
- 2 tablets (1 gram) by oral route 4 times per day for 3 weeks
- 2 tablets (1 gram) by oral route 4 times per day for 4 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day
- 3 tablets (1.5 gram) by oral route 4 times per day for 3 weeks
- 3 tablets (1.5 gram) by oral route 4 times per day for 4 weeks
Rheumatic fever prevention
- 2 tablets (1 gram) by oral route once daily
- Hiprex
- methen-sod phos-meth blue-hyos
- methenamine hippurate
- methenamine mand-sod biphos
- methenamine mandelate
- typhoid vaccine
- Urogesic-blue
- Uroqid-acid No.2
- Uryl
- Vivotif Berna Vaccine
Contraindicated
- Coumadin
- cyclosporine
- cyclosporine modified
- Folotyn
- Gengraf
- Jantoven
- Methotrexate (anti-rheumatic)
- methotrexate sodium
- methotrexate sodium (PF)
- Neoral
- pralatrexate
- Rheumatrex
- Sandimmune
- Trexall
- warfarin
Severe
Moderate
- Bio-35
- Bio-35, Gluten Free
- Body, Hair, Skin & Nails
- Cerebyx
- Dilantin
- Dilantin Extended
- Dilantin Infatabs
- Dilantin Kapseal
- Dilantin-125
- ethotoin
- fosphenytoin
- glucosamine-chondr-mv antiox#5
- Maximum Daily Green
- multivit & min-FA-diet comb 19
- mv,Ca,ir,min-FA-lut-lyco-hc153
- mv,Ca,ir,Mn-FA-cho-gel-ino-PAB
- mv,iron,min-FA-dietary cmb.24
- mv-Ca-Mn-iron-FA-lut-ly-hb#175
- mv-iron-FA-Ca-beepoln-hb 101
- mv-iron-min-FA-ino-chol-PABA
- mv-mn-FA-lycopene-lut-#178herb
- Peganone
- Phenytek
- phenytoin
- phenytoin sodium
- phenytoin sodium extended
- Relamine
- Super Multiple
- Super Multiple - Low Iron
- Hemolytic anemia from PK and g6PD deficiencies
- Lactating mother
- Pregnancy- third trimester
Contraindicated
- Blood dyscrasias
- Disease of liver
- Folic acid deficient megaloblastic anemia
- Kidney disease with reduction in GFR
- Porphyria
Severe
Moderate
- None
SULFADIAZINE (SULFADIAZINE)
- AIDS with toxoplasmosis
- Bacterial urinary tract infection
- Congenital toxoplasmosis
- Encephalitis due to toxoplasmosis
- Nocardiosis
- Rheumatic fever prevention
- Toxoplasmosis
- Drug fever
- Skin photosensitivity
- Anorexia
- Diarrhea
- Dizziness
- Headache disorder
- Lethargy
- Nausea
- Pruritus of skin
- Skin rash
- Vomiting
More Frequent
Severe
Less Severe
- Hepatitis
- Stevens-johnson syndrome
- Toxic epidermal necrolysis
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acidosis
- Agranulocytosis
- Alveolitis
- Anaphylaxis
- Angioedema
- Anuria
- Aplastic anemia
- Behcet syndrome
- Cauda equina syndrome
- Clostridium difficile infection
- Crystalluria
- Cyanosis
- DRESS syndrome
- Dyspnea
- Enterocolitis
- Eosinophilia
- Eosinophilic pneumonia
- Erythema multiforme
- Erythema nodosum
- Exfoliative dermatitis
- Gastrointestinal hemorrhage
- Glucose-6-phosphate dehydrogenase deficiency anemia
- Goiter
- Granulocytopenic disorder
- Guillain-barre syndrome
- Hematuria
- Hemolytic anemia
- Hemolytic uremic syndrome
- Hepatic necrosis
- Hepatocellular damage
- Hypofibrinogenemia
- Hyponatremia
- Hypoprothrombinemia
- Hypothyroidism
- Interstitial nephritis
- Intracranial hypertension
- Leukopenia
- Lupus-like syndrome
- Megaloblastic anemia
- Methemoglobinemia
- Myelodysplastic syndrome
- Myocarditis
- Neutropenic disorder
- Oliguria
- Pancreatitis
- Pericarditis
- Periorbital edema
- Pleuritis
- Polyarteritis nodosa
- Proteinuria
- Pulmonary infiltrates
- Purpura
- Renal tubular necrosis
- Seizure disorder
- Serum sickness
- Thrombocytopenic disorder
- Thrombotic thrombocytopenic purpura
- Urolithiasis
- Vasculitis
Less Severe
- Acute abdominal pain
- Acute confusion
- Alopecia
- Arthralgias
- Ataxia
- Black tarry stools
- Chills
- Cough
- Depression
- Drowsy
- Drug-induced psychosis
- Fatigue
- Flatulence
- Gastroenteritis
- General weakness
- Glossitis
- Hallucinations
- Hearing loss
- Hypoglycemic disorder
- Indifference
- Insomnia
- Nervousness
- Paresthesia
- Peripheral neuropathy
- Stomatitis
- Symptoms of anxiety
- Tinnitus
- Urticaria
- Vertigo
Contraindicated
Sulfadiazine
Exceptional use for congenital toxoplasmosis, rheumatic fever prophylaxis.
- 1 Day – 59 Days
- 1 Exceptional use for congenital toxoplasmosis, rheumatic fever prophylaxis.
Severe Precaution
None
Management or Monitoring Precaution
None
Sulfadiazine
- Severity Level:
1
- Additional Notes: Fda rating c; contraindicated near or at term, may cause kernicterus in newborn
Contraindicated
Sulfadiazine
Do not breast feed if infant is hyperbilirubinemic or g6Pd deficient
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Excreted | Drug shown to have adverse effect | Do not breast feed if infant is hyperbilirubinemic or g6Pd deficient |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| AIDS with toxoplasmosis | |
| B20 | Human immunodeficiency virus [HIv] disease |
| B58.2 | Toxoplasma meningoencephalitis |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
| Bacterial urinary tract infection | |
| N30.0 | Acute cystitis |
| N30.00 | Acute cystitis without hematuria |
| N30.01 | Acute cystitis with hematuria |
| N30.9 | Cystitis, unspecified |
| N30.90 | Cystitis, unspecified without hematuria |
| N30.91 | Cystitis, unspecified with hematuria |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| O23.90 | Unspecified genitourinary tract infection in pregnancy, unspecified trimester |
| O23.91 | Unspecified genitourinary tract infection in pregnancy, first trimester |
| O23.92 | Unspecified genitourinary tract infection in pregnancy, second trimester |
| O23.93 | Unspecified genitourinary tract infection in pregnancy, third trimester |
| P39.3 | Neonatal urinary tract infection |
| T83 | Complications of genitourinary prosthetic devices, implants and grafts |
| T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.51 | Infection and inflammatory reaction due to urinary catheter |
| T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.6 | Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract |
| Congenital toxoplasmosis | |
| P37.1 | Congenital toxoplasmosis |
| Encephalitis due to toxoplasmosis | |
| B58.2 | Toxoplasma meningoencephalitis |
| Nocardiosis | |
| A43 | Nocardiosis |
| A43.0 | Pulmonary nocardiosis |
| A43.1 | Cutaneous nocardiosis |
| A43.8 | Other forms of nocardiosis |
| A43.9 | Nocardiosis, unspecified |
| Rheumatic fever prevention | |
| B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
| J02.0 | Streptococcal pharyngitis |
| J03.00 | Acute streptococcal tonsillitis, unspecified |
| Toxoplasmosis | |
| B58 | Toxoplasmosis |
| B58.0 | Toxoplasma oculopathy |
| B58.00 | Toxoplasma oculopathy, unspecified |
| B58.01 | Toxoplasma chorioretinitis |
| B58.09 | Other toxoplasma oculopathy |
| B58.1 | Toxoplasma hepatitis |
| B58.2 | Toxoplasma meningoencephalitis |
| B58.3 | Pulmonary toxoplasmosis |
| B58.8 | Toxoplasmosis with other organ involvement |
| B58.81 | Toxoplasma myocarditis |
| B58.82 | Toxoplasma myositis |
| B58.83 | Toxoplasma tubulo-interstitial nephropathy |
| B58.89 | Toxoplasmosis with other organ involvement |
| B58.9 | Toxoplasmosis, unspecified |
| 0-9 | A-Z |
|---|---|
| A43 | Nocardiosis |
| A43.0 | Pulmonary nocardiosis |
| A43.1 | Cutaneous nocardiosis |
| A43.8 | Other forms of nocardiosis |
| A43.9 | Nocardiosis, unspecified |
| B20 | Human immunodeficiency virus [HIv] disease |
| B58 | Toxoplasmosis |
| B58.0 | Toxoplasma oculopathy |
| B58.00 | Toxoplasma oculopathy, unspecified |
| B58.01 | Toxoplasma chorioretinitis |
| B58.09 | Other toxoplasma oculopathy |
| B58.1 | Toxoplasma hepatitis |
| B58.2 | Toxoplasma meningoencephalitis |
| B58.2 | Toxoplasma meningoencephalitis |
| B58.2 | Toxoplasma meningoencephalitis |
| B58.3 | Pulmonary toxoplasmosis |
| B58.8 | Toxoplasmosis with other organ involvement |
| B58.81 | Toxoplasma myocarditis |
| B58.82 | Toxoplasma myositis |
| B58.83 | Toxoplasma tubulo-interstitial nephropathy |
| B58.89 | Toxoplasmosis with other organ involvement |
| B58.9 | Toxoplasmosis, unspecified |
| B95.0 | Streptococcus, group a, as the cause of diseases classified elsewhere |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
| J02.0 | Streptococcal pharyngitis |
| J03.00 | Acute streptococcal tonsillitis, unspecified |
| N30.0 | Acute cystitis |
| N30.00 | Acute cystitis without hematuria |
| N30.01 | Acute cystitis with hematuria |
| N30.9 | Cystitis, unspecified |
| N30.90 | Cystitis, unspecified without hematuria |
| N30.91 | Cystitis, unspecified with hematuria |
| N39.0 | Urinary tract infection, site not specified |
| O23.0 | Infections of kidney in pregnancy |
| O23.00 | Infections of kidney in pregnancy, unspecified trimester |
| O23.01 | Infections of kidney in pregnancy, first trimester |
| O23.02 | Infections of kidney in pregnancy, second trimester |
| O23.03 | Infections of kidney in pregnancy, third trimester |
| O23.1 | Infections of bladder in pregnancy |
| O23.10 | Infections of bladder in pregnancy, unspecified trimester |
| O23.11 | Infections of bladder in pregnancy, first trimester |
| O23.12 | Infections of bladder in pregnancy, second trimester |
| O23.13 | Infections of bladder in pregnancy, third trimester |
| O23.2 | Infections of urethra in pregnancy |
| O23.20 | Infections of urethra in pregnancy, unspecified trimester |
| O23.21 | Infections of urethra in pregnancy, first trimester |
| O23.22 | Infections of urethra in pregnancy, second trimester |
| O23.23 | Infections of urethra in pregnancy, third trimester |
| O23.3 | Infections of other parts of urinary tract in pregnancy |
| O23.30 | Infections of other parts of urinary tract in pregnancy, unspecified trimester |
| O23.31 | Infections of other parts of urinary tract in pregnancy, first trimester |
| O23.32 | Infections of other parts of urinary tract in pregnancy, second trimester |
| O23.33 | Infections of other parts of urinary tract in pregnancy, third trimester |
| O23.4 | Unspecified infection of urinary tract in pregnancy |
| O23.40 | Unspecified infection of urinary tract in pregnancy, unspecified trimester |
| O23.41 | Unspecified infection of urinary tract in pregnancy, first trimester |
| O23.42 | Unspecified infection of urinary tract in pregnancy, second trimester |
| O23.43 | Unspecified infection of urinary tract in pregnancy, third trimester |
| O23.90 | Unspecified genitourinary tract infection in pregnancy, unspecified trimester |
| O23.91 | Unspecified genitourinary tract infection in pregnancy, first trimester |
| O23.92 | Unspecified genitourinary tract infection in pregnancy, second trimester |
| O23.93 | Unspecified genitourinary tract infection in pregnancy, third trimester |
| P37.1 | Congenital toxoplasmosis |
| P39.3 | Neonatal urinary tract infection |
| T83 | Complications of genitourinary prosthetic devices, implants and grafts |
| T83.5 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.51 | Infection and inflammatory reaction due to urinary catheter |
| T83.59 | Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system |
| T83.6 | Infection and inflammatory reaction due to prosthetic device, implant and graft in genital tract |
Formulary Reference Tool